Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Update and recommendations: Pharmacists’ prescriptive authority for tobacco cessation medications in the United States

Journal of the American Pharmacists Association(2022)10.1016/j.japh.2022.06.005Source: DataRank Database

Update and recommendations: Pharmacists’ prescriptive authority for tobacco cessation medications in the United States is a research paper published in Journal of the American Pharmacists Association (2022). On theSindex it has a DataRank of 0. It has been cited 19 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access19 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 2.22)OA: greenTopics (48)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Robin L. Corelli ORCID,Veronica Vernon ORCID,Karen Suchanek Hudmon ORCID,Katy Ellis Hilts ORCID

Live enrichment

PubMed:35953378 PMC:PMC9464677 OpenAlex:https://openalex.org/W4283118829

National Cancer Institute

Grant: R25 CA236637

National Cancer Institute

Grant: T32 CA117865

NIGMS NIH HHS

Grant: P20 GM121176

National Institutes of Health

Grant: 5R25CA236637-04

Advancing the Role of Pharmacy in Tobacco Cessation

National Institutes of Health

Grant: 2T32CA117865-16A1

Interdisciplinary Training in Cancer Prevention and Control

National Cancer Institute Division of Cancer Prevention

National Institutes of Health

FWCI

2.22

Citation Percentile

0.9%

Citation Trend

2023

2024

2025

greenLicense: Elsevier TDM

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9464677

BRONZEhttp://manuscript.elsevier.com/S1544319122002187/pdf/S1544319122002187.pdf

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9464677

publisherhttps://api.elsevier.com/content/article/PII:S1544319122002187?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1544319122002187?httpAccept=text/plain

Fields of Study

Smoking Behavior and CessationHealth Policy Implementation ScienceSchool Health and Nursing EducationMedicineLaw03 medical and health sciences0302 clinical medicineHumansNew MexicoPharmacistsSmoking CessationTobacco Use CessationTobacco Use Cessation DevicesUnited States

MeSH Terms

HumansNew MexicoPharmacistsUnited StatesSmoking CessationTobacco Use CessationTobacco Use Cessation Devices

Keywords

MedicineSmoking cessationLegislationPharmacyPharmacistIntervention (counseling)LegislatureFamily medicineDocumentationNicotine replacement therapyTobacco controlPublic healthNursingLawPolitical scienceTobacco Use CessationNew Mexico610Pharmacist prescribingPharmacistsTobacco Use Cessation DevicesUnited StatesTobacco cessation615Pharmacist prescriptive authorityHumansScope of practice

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being